研究报告ResearchReport27Mar2024华润医药ChinaResourcesPharmaceutical(3320HK)2023年报点评:内生外延扩充业务版图,资源协同实现可持续增长FY23Review:EndogenousandExogenousExpansionofBusinessTerritory,Re...